MARKET WIRE NEWS
  1. Home
  2. Stock
  3. LYEL
  4. News
  5. Lyell Immunopharma Strengthens Clinical And Commerci
LYEL
Quote
Short
News
Articles
Message Board

Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments

Source: SeekingAlpha

2025-06-10 01:52:53 ET

More on Lyell Immunopharma

Read the full article on Seeking Alpha

For further details see:

Lyell Immunopharma strengthens clinical and commercial capabilities with executive appointments
Lyell Immunopharma Inc.

NASDAQ: LYEL

LYEL Trading

-2.39% G/L:

$24.305 Last:

28,591 Volume:

$24.69 Open:

mwn-link-x Ad 300

LYEL Latest News

March 10, 2026 07:00:21 am
Expected US Company Earnings on Tuesday, March 10th, 2026
March 09, 2026 08:00:00 am
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer 
February 23, 2026 08:00:00 am
Lyell Immunopharma Announces Participation in March Investor Conferences
February 12, 2026 07:30:00 am
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma

LYEL Stock Data

$503,932,654
12,184,349
0.5%
11
N/A
Biotechnology & Life Sciences
Healthcare
https://www.lyell.com
US
South San Francisco

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App